Phase 3 Leishmaniasis Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.
Leishmaniasis, Cutaneous
Universidad de Antioquia96 enrolled1 locationNCT06822478
Recruiting
Phase 3
Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan
Old World Cutaneous Leishmaniasis
Medecins Sans Frontieres, Netherlands832 enrolled2 locationsNCT04268524
Recruiting
Phase 2Phase 3
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
Leishmaniasis, MucocutaneousLeishmaniasis; Brazilian
University of Brasilia100 enrolled1 locationNCT06040489
Completed
Phase 2Phase 3
Liposomal amphotericin B for the treatment of Nepalese patients with visceral leishmaniasis.
Visceral Leishmaniasis
The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35 enrolled1 locationACTRN12610000130066
Active
Phase 2Phase 3
Liposomal amphotericin B for the treatment of Bangladeshi patients with visceral leishmaniasis.
Visceral leishmaniasis (VL)
The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35 enrolled1 locationACTRN12609001029280